ProBiotix Health Plc (FRA:X90)

Market Cap	19.37M +17.9%
Revenue (ttm)	3.13M +45.1%
Net Income	-1.41M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1010
Previous Close	0.0890
Day's Range	0.0890 - 0.1010
52-Week Range	0.0390 - 0.1010
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About ProBiotix Health

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. The company offers YourBiotixMH for menopause health; YourBiotixCH InstaMelt and YourBiotixCH for cholesterol maintenance; and YourBiotixX3 for cholesterol reduction. It also provides YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in Fe...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Employees: 12
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: X90

Financial Performance

In 2025, ProBiotix Health's revenue was 2.73 million, an increase of 45.09% compared to the previous year's 1.88 million. Losses were -1.23 million, 45.6% more than in 2024.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error